Erste Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Erste Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,300	Closed	-$171K	–	574
2021 Q4	$171K	Hold	18,300	–	–	﹤0.01%	497
2021 Q3	$616K	Hold	18,300	–	–	0.01%	382
2021 Q2	$671K	Hold	18,300	–	–	0.01%	379
2021 Q1	$760K	Hold	18,300	–	–	0.02%	352
2020 Q4	$1.01M	Hold	18,300	–	–	0.03%	333
2020 Q3	$907K	Hold	18,300	–	–	0.03%	307
2020 Q2	$1.07M	Hold	18,300	–	–	0.04%	288
2020 Q1	$767K	Buy	+18,300	New	+$1.02M	0.04%	281

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Erste Asset Management's DCPH Position: Q1 2022 in Review

Erste Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 18,300 shares — an estimated $171K sold.

Erste Asset Management first reported a position in DCPH in Q1 2020 and held it in 8 quarters. The position peaked at $1.07M in Q2 2020. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Erste Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Erste Asset Management sold 18,300 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $171K.
Erste Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
Erste Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.07M in Q2 2020.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.